Perigon Wealth Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Perigon Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$27.79 - $50.61 $142,090 - $258,768	-5,113 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $3,565 - $6,297	90 Added 1.79%	5,113 $235,000
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $58 - $82	1 Added 0.02%	5,023 $333,000
Q3 2021 Nov 01, 2021	BUY	$58.38 - $84.96 $293,184 - $426,669	5,022 New	5,022 $314,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.